| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Sustainability Consult Credible sustainability & bioeconomy communications. Led by Conscious Business Leader Kathryn Sheridan since 2008. Sustainability Consult is dedicated to raising Credibility and Visibility for organisations worldwide. We are the leading bioeconomy communications and PR agency, based in Brussels, operating internationally. A trusted partner and recognised source for the media, Sustainability Consult has a proven track record in brand building, corporate communications and PR. We offer a full service of high-level consultancy services, from PR to communications and online strategy, through to issues management and crisis communications, as well as events, reports and media monitoring. We tweet @SustConsult. Follow us on … Type: | 9 | 3 | 6 | 1 |
 | Acteurs de La French Care [Automatic translation follows] The grouping of players who support and develop the health ecosystem in France! The grouping of players who support and develop the health ecosystem in France! Type: | 22 | 4 | 19 | 1 |
 | La Course des Lumières [Automatic translation follows] Together, let's light up the night against illness and for all sick people! Created in 2010, the Race of Lights is a national awareness event around the fight against disease. Since its creation, more than a million euros have been collected for the benefit of health organizations (foundations, hospitals, patient associations, etc.). Accessible to all, the event brings together more than 15,000 participants and 200 companies each year. Each participant, runner or walker, symbolically carries a luminous object to “light the night against illness and for all sick people”. solidarity, sport, running, walking, and team-building Type: | 5 | 5 | 1 | 1 |
 | BIOKET Bioeconomy Key Enabling Technologies platform Process & Technology innovations for biobased solutions to food, feed, chemicals, biomaterials and bioenergies Trois-Rivières (QC), Canada -- May 23th-25th, 2023 -- Biomass is a wonderful ressource to be transformed into chemicals, biobased materials, food and feed ingredients or energy. Still, adaptation and optimisation of transformation processes and technologies is a real challenge in order to valorise all biomass fraction in a circular approach. In the context of Industry 4.0, the circular economy and the need for an optimal valorization of renewable resources, BIOKET is the only European conference dedicated to bio-based technologies and processes. Innovative Processes, Biotechnology, Green Chemistry, … Type: | 28 | 9 | 22 | 2 |
 | Catsalyze We improve your enzymes. Catsalyze will revolutionize enzymatic biocatalyze. Our proprietary technology allows us to graft enzymes around a protein ring, which gives them strong advantages such as increased stability, solubility, efficiency but also the possibility of assembling these grafted rings to create perfectly colocalized enzymatic cascades. . So extremely effective. Our challenge? Transform biomass in a gentle and clean way and through accelullar enzymatic catalysis into chemical bricks classically petrosourced and synthesized with pollution. The future of chemistry passes through Catsalyze. Type: | 24 | 4 | 21 | 2 |
 | Talas Partners [Automatic translation follows] The right financing at the right time! Talas Partners is your partner of excellence to propel your company's innovation towards new horizons. Who are we ? Much more than a simple innovation financing consultancy firm, we become your partner to achieve your entrepreneurial objectives and lead you towards success. Our passion is to transform each innovative project into a successful entrepreneurial success. Our mission We have a clear mission: to help Startups and SMEs develop their businesses by mobilizing public or private financing. Our Support Present in the innovation ecosystem for a very long time, we guide … Type: | 4 | 1 | 3 | 3 |
 | RELEVATION The Global digital fundraising Summit for PropTech startups Relevation.org is the global digital investment summit in UrbanTech; a 2 days event of match-making between investors (BA, family offices, VC, CVC...) and startups across all the stages of maturity in fund raising process Type: | 21 | 3 | 20 | 3 |
 |  EryPharm EryPharm is a biotech start-up company dedicated to the development and the operation of a large-scale process for the production of Red Blood Cells from stem cells. The technology has been developed by Dr. Luc Douay and his team at the Paris Sorbonne university. You can contact EryPharm through our website: http://erypharm.com/contact.html Or you can contact Loïc Tron directly: www.linkedin.com/in/loictron Type: | 9 | 1 | 8 | 3 |
 | Cancer Campus [Automatic translation follows] Cancer Campus is a research and innovation park developing in Villejuif (Val-de-Marne) Cancer Campus is a research and innovation park developing in Villejuif (Val-de-Marne), around Gustave Roussy, the first cancer center in Europe. Its objective is to bring together all the talents (health professionals, researchers, students, businesses) and citizens concerned by the disease to become an international reference site in innovation in health and oncology. In this context, we are developing 3 programs dedicated to promoting entrepreneurship in oncology: - the Oncoentrepreneur program: tailor-made training and support set up for start-up projects in biotech, medtech and e-health. … Type: | 5 | 1 | 3 | 3 |
 | mind Health [Automatic translation follows] The business intelligence service dedicated to the digital transformation of healthcare industries. mind Health is a B2B service offering dedicated to the transformation of health industries, innovation and the transformation of the value chain in the health ecosystem. Offering information, monitoring and analysis, mind Health is aimed at all the players and sectors that make up this ecosystem: pharmaceutical and medical device industries, electronics, IT and telecoms, mutual funds and insurance, healthcare services. public and private, service providers... Type: | 70 | 3 | 69 | 4 |
 | VERTEXA Digital Therapeutics [Automatic translation follows] VERTEXA is an immersive therapeutic game, in virtual reality. Let’s digitalize health! VERTEXA digital therapy (Virtual Reality Therapy Exposition in Anorexia) aims to use virtual reality as a support tool in the form of a gamified and immersive psychoeducational course in patients suffering from eating disorders (anorexia, bulimia). The use of digital tools and new technologies now allow an innovative, personalized, motivating and accessible approach regardless of where our patients are cared for. The VERTEXA tool is intended to be autonomous: the patient is involved in his or her care. He will be immersed in a soothing … Type: | 21 | 2 | 21 | 4 |
 | The Drawdown The essential resource for private equity operations The Drawdown provides vital insight and analysis for mid and back office private equity professionals, including COOs, CFOs and investor relations. Our publication addresses and explores new demands facing the industry, as well as wider issues, to improve the effectiveness of private equity, and to maintain the industry’s leading status by encouraging responsible, socially aware behaviours. The Drawdown produces monthly magazines, daily online content, regular newsletters and several events. Sign up at The-Drawdown.com Private equity, Media, Events, Analysis, and Insight Type: | 8 | 2 | 7 | 5 |
 | LSX LSX is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. Our community helps catalyse early stage innovation through peer-to-peer education and knowledge sharing, networking, partnering and deal making to champion the most innovative and exciting ideas. We bring deals to life., LSX is the network for life science executive leaders. Take a … Type: | 30 | 4 | 20 | 5 |
 | AFI Ventures Europe’s Day-One Impact Launchpad At AFI Ventures, we are committed to backing the most promising seed & pre-seed impact entrepreneurs. From climate action to healthy living, we partner with every visionary that shares the ambition of deep, at-scale impact. We are investing up to 500k€ in 1 to 2 companies every month. AFI Ventures is the seed fund of Alliance for Impact, Europe's day one impact launchpad. impactinvesting, capitalrisque, VC, impact, startup, fonds, seed, financement, entrepreneurship, and socialbusiness Type: | 15 | 11 | 4 | 5 |
 | Linklaters Linklaters is a leading global law firm, supporting and investing in the future of our clients wherever they do business. We combine legal expertise with a collaborative and innovative approach to help clients navigate constantly evolving markets and regulatory environments, pursuing opportunities and managing risk worldwide. http://www.linklaters.com Attorney Advertising: Prior results do not guarantee a similar outcome Type: | 16 | 10 | 4 | 6 |
 | Frst We are the first believers Frst is a Day One venture firm focused on supporting a new generation of French entrepreneurs with global ambitions. €200m+ AUMA invested in 50+ companies to date. Full portfolio on frst.vc Type: | 6 | 5 | 0 | 6 |
 | MSInsight Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status. MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker. We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for … Type: | 32 | 6 | 31 | 6 |
 | Quest for health [Automatic translation follows] Healthcare accelerator in the heart of Europe. For biotech, medtech and digital health startups. Quest for health is the Grand Est incubator dedicated to health start-ups at European level. Born from the initiative of the Quest for change network of incubators (based in Reims, Strasbourg, Metz, Charleville-Mézières, Epinal and Mulhouse), the incubator supports more than sixty biotech, medtech and e-health start-ups. Quest for health is positioned as the leading player at the national level in this field. Among the start-ups supported, 21 are winners of the national i-Lab competition (including four grand prizes), five of the i-Nov … Type: | 40 | 11 | 38 | 6 |
 | La French Care [Automatic translation follows] The movement of health actors Our mission ? Federate the health ecosystem. French Care is the movement of health actors, it is supported by Bpifrance and the Acteurs de la French Care association, which brings together private and public actors in the health sector in France. French Care serves the development of ecosystems and excellence in the service of the patient. The mission of La French Care: to promote and develop excellence in health in France. Type: | 18 | 10 | 8 | 6 |
 | IMS (Institut du Médicament de Strasbourg) [Automatic translation follows] Interdisciplinary Thematic Institute of the University of Strasbourg The Strasbourg Medicine Institute responds to the challenges of the medicines sector: producing cutting-edge research up to the pre-clinical stage, promoting technological innovation through the creation of start-ups and training the new generation of researchers in management of drug innovation. Type: | 13 | 2 | 7 | 6 |
 | France Deeptech [Automatic translation follows] When science undertakes The community that brings together deeptech players for an entrepreneurial, collective and scientific response to our contemporary challenges Type: | 44 | 11 | 39 | 6 |
 | MATWIN French Accelerator dedicated to innovation in oncology MATWIN (Maturation & Accelerating Translation With INdustry) est un programme accélérateur pour développer la recherche translationnelle en cancérologie et faciliter le transfert des innovations vers les patients. Son objectif principal est d'accompagner des projets innovants (issus de laboratoires académiques ou portés par des startups) et présentant un fort potentiel de développement en favorisant des partenariats précoces. Le programme s’appuie sur un partenariat avec de grands laboratoires engagés en oncologie (Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Exact Sciences, Gilead, GlaxoSmithKline, Nanostring Technologies, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi) et l’ensemble des acteurs soucieux de … Type: | 47 | 6 | 43 | 7 |
 | MedTech in France [Automatic translation follows] We are the French medical technology companies, we innovate every day for patients! Created in 2013, MedTech in France currently brings together more than 40 French companies in the health MedTech sector. and telemedicine, optical technologies, surgical robotics, and even medical imaging. The Association develops concrete solutions to promote market access, innovations and highlight French excellence in medical technologies. It has also set itself the mission of creating French champions internationally. MedTech in France has set itself a triple ambition: > provide medical solutions for patients and caregivers > bring economic and organizational benefits to the health … Type: | 25 | 5 | 22 | 7 |
 | Enersens Enersens produces the best thermal barriers and additives to improve safety, energy efficiency and flame protection Enersens is a leading innovative company specializing in silica aerogel products. We develop and market high performance aerogel-based insulation materials. We aim to become the leader in these high performance materials to enable our customers and partners to achieve their own goals around global trends in energy efficiency, sustainability, electric mobility and clean energy. Our Skogar® products solve the thermal runaway problems of batteries for any type of electric vehicle or electric mobility. Their performance and finesse also make it possible to solve many … Type: | 23 | 5 | 21 | 7 |
 | AudioTelligence Disruptive hearing technology start-up (CLOSED) Situational hearing loss is a huge and growing problem worldwide, affecting over 80% of people over 40. Often called ‘The Cocktail Party Problem’, this means that sufferers can hear speech clearly in quiet rooms, but in noisy situations they find it hard to follow conversations. AudioTelligence’s aisoTM technology can supercharge hearing enhancement on your device. AisoTM goes a step further than other solutions which simply reduce background noise, by isolating and extracting the speech or sound that the user wants to hear from surrounding noise and unwanted sounds. With aisoTM, users can effectively regain their … Type: | 17 | 0 | 15 | 7 |
 | SISTAFUND We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams. SISTAFUND is a pan-European VC fund backing female founders and gender-balanced teams, building companies that challenge the status quo. With a target of €100 million, SISTAFUND will be deployed from pre-seed to Series A, mainly in France and Europe, with some investments in the U.S. SISTAFUND’s ambition is twofold: Drive the performance of backed companies, since start-ups founded or co-founded by women are 2.5 times more profitable investments … Type: | 48 | 11 | 45 | 7 |
 | GIMLI Leverage Real World Evidence in oncology Gimli empowers medical professionals to structure medical data. We extract and structure data directly from the EMR to streamline RWD, allowing the generation of strong RWE. Ask us for a demo! Gimli is a Startup working with university hospitals, pharmaceutical companies, data analytics providers, and startups. Type: | 21 | 2 | 11 | 7 |
 | Private Equity Magazine [Automatic translation follows] The monthly magazine for private equity professionals Find the latest news from investment capital professionals on our site and our magazine. Deals, surveys and analyses, with a cumulative audience of more than 30,000 readers, Private Equity Magazine has become for 10 years the reference publication for French and European private equity players. Type: | 75 | 14 | 72 | 8 |
 | M&M Conseil [Automatic translation follows] Public affairs - Institutional relations M&M Conseil has specialized in the organization of institutional events and public affairs consulting for more than 25 years. Close to French and European institutions, we organize key meetings between public, private and institutional stakeholders. Public Affairs Consulting, Institutional Communication, Events, and Public Relations Type: | 86 | 6 | 83 | 8 |
 | HealthTech For Care An endowment fund to support and promote access to care for all patients as well as new medical and drug technologies. The HealthTech For Care endowment fund has three essential missions: - fostering the growth and development of the entire health ecosystem, - advocating for the advancement of innovative therapies and treatments to benefit patients, - promoting enhanced access to care for patients within the European healthcare ecosystem. The HealthTech For Care endowment fund has been founded by France Biotech. Health Type: | 22 | 5 | 20 | 8 |
 | Groupe Stratos Groupe STRATOS is an entrepreneurs community providing companies with custom-made solutions. Groupe STRATOS is an entrepreneurs community providing companies with custom-made solutions. Our community is composed of entrepreneurs with expertise on a specific topic and each single member is/was an entrepreneur. Groupe STRATOS was founded in 2020 with the merger of 2 other companies created 10 & 20 years ago. About our advisory activiy : - Fund raisings through our network of +1 000 investors (France & International) - Mergers & Acquisitions - Financial audits (M&A, valuation of companies, due diligence...) - Financial analysis - Strategy & business development - … Type: | 54 | 2 | 54 | 8 |
 | BeBeez Italia [Automatic translation follows] The first publisher specializing in news and services on private investments in venture and debt capital EdiBeez is the publisher of BeBeez.it and CrowdfundingBuzz.it BeBeez is an online newspaper registered with the Court of Milan (Authorization no. 102 of 3 April 2013), born in the spring of 2013 from an idea by Stefania Peveraro (head of service of MF Milano Finanza) and Anna Gervasoni (general director of the Italian Association of Private Equity and Venture Capital, AIFI). Crowdfunding Buzz is a magazine dedicated to collecting news and information relating to all forms of crowdfunding. Born in December … | 35 | 0 | 35 | 9 |
 | Labiotech.eu The leading digital media covering global biotech innovation Labiotech.eu is the leading digital media covering the global biotech industry. Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Join them now and enjoy reading our stories! "We are building the Next Generation of Digital Media for Biotech" Philip & Joachim, Founders of Labiotech.eu Biotechnology, Life science, News, and Media Type: | 21 | 3 | 18 | 9 |
 | BIOTECHFINANCES [Automatic translation follows] 1st weekly specialist information, biotech, medtech, e-health, finance published by Jacques Bernard Taste PRESENTATION The weekly Biotech Finances letter approaches from an economic and financial angle all questions linked to the development of the biotechnology sector and more broadly life sciences. Our target readership is mainly composed of biotechnology companies focused on health and the development of new therapies and new treatments for diseases, pharmaceutical companies (big pharma and other laboratories), investors, business angels, funds investments, venture capital, specialists in the biotech sector, institutional investors, legal advisors, development experts, and service providers and equipment suppliers. Our articles … Type: | 13 | 4 | 3 | 9 |
 | Kickston [Automatic translation follows] Fundraising I M&A Kickston is a merchant bank that supports entrepreneurs in their fundraising and M&A operations. Industries: Consumer & B2B Tech • Fundraising: 2 to 10M€ • Transfer: Operations up to €15M Are you interested in our approach? Contact us! contact@kickston.co Type: | 27 | 1 | 27 | 9 |
 | Home Biosciences A new breed of biotech company A new breed of biotech company aiming to unlock scientific breakthrough by leveraging an asset-centric operating model Type: | 5 | 4 | 2 | 9 |
 | Drug Discovery World The Global Business Review of Drug Discovery and Development Welcome to our LinkedIn page. This is where we will share original content from the DDW team and industry experts, as well as daily news and other company updates. Published for over 20 years, DDW is the only truly global business review of all aspects of drug discovery and development and has firmly established itself as a highly respected and ‘must read’ journal within the discovery and development arena. DDW is renowned for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised ‘platform’ for ‘Industry … Type: | 19 | 2 | 17 | 9 |
 | Dieter von Holtzbrinck Ventures DvH Ventures | Investing early in Europe's most passionate founders. Dieter von Holtzbrinck Ventures (DvH Ventures) is one of Europe's leading early stage investors. As an entrepreneurial venture capitalist, DvH Ventures invests in emerging technology companies and builds successful investment clusters in areas such as Digital Health, Education, DeepTech or Climate Tech/ESG. Founded in 2014, partners Duc Quyen Tran, Peter Richarz and Fabian von Trotha manage several venture capital funds from their Cologne office. In addition to financial investments, DvH Ventures supports its portfolio companies with management expertise, in-depth industry knowledge and an international investor network. An exclusive media-for-equity programme … Type: | 25 | 6 | 18 | 10 |
 | TECHNION FRANCE [Automatic translation follows] French representation of the Technion, Israel Institute Of Technology The Technion France's mission is to promote the Technion, Israel Institute of Technology, in scientific, industrial and economic circles and to publicize the Technion's achievements and projects in the fields of scientific and technological research. In addition, it intends to encourage the establishment of close relationships between these environments and all the scientists, teachers and students of the Technion, for the development of cooperation on projects of common interest. It also aims to increase the number of events and conferences in France by inviting professors specializing in Israel. … Type: | 43 | 13 | 28 | 11 |
 |  AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 0 | 1 | 11 |
 | Marsh We help our clients and colleagues grow — and our communities thrive — by protecting and promoting Possibility. We help our clients and colleagues grow — and our communities thrive — by protecting and promoting Possibility. We seek better ways to manage risk and define more effective paths to the right outcome. We go beyond risk to rewards for our clients, our company, our colleagues, and the communities in which we serve. Marsh is the world’s leading insurance broker and risk advisor. With over 45,000 colleagues operating in 130 countries, Marsh serves commercial and individual clients with data-driven risk solutions … Type: | 10 | 7 | 3 | 12 |
 | TAC ECONOMICS An independent European research group providing advisory services on international economic and financial issues TAC ECONOMICS is a French independent leading provider of economic and financial consulting services with a strong expertise on country risk based on AI and data-driven solutions. Our team of experienced economists and data scientists specializes in providing cutting-edge data, models, and analysis to help our clients detect major risks and evaluate investment opportunities. Our commitment to AI and data-driven solutions is rooted in our pioneering work in the early 1990s, where we developed artificial intelligence tools to predict financial crises in emerging economies and prevent … | 6 | 1 | 3 | 12 |
 | Institut G9+ L'Interclubs Numérique des Alumni des Grandes Écoles & Universités The G9 + Institute is a plural and apolitical think tank, promoting digital development in France. Federating 24 graduate communities of universities and colleges, and 50000 alumni, the G9 + Institute is one of the reference think tanks of digital for more than 22 years. Engaged in its historical mission of consultative source of proposals, the G9 + Institute wants to allow its members and friends to confront their ideas, deepen them and make them known. It brings an investigative, constructive and audacious light by publishing white papers and organizing about … Type: | 43 | 12 | 31 | 12 |
 | Myricx Bio Developing a new class of ADCs based on NMT inhibition to treat cancer We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer. Type: | 2 | 1 | 1 | 12 |
 | Asabys Partners Investing in Life. Investing in Science. Investing in Future. Asabys Partners is a venture capital firm from Barcelona investing across the board in human healthcare. We are active in the health-tech and biopharma industries and aim to invest in Spain and abroad in highly innovative and transformative technologies. We are motivated by the idea of pushing the boundaries of science and medicine. We do this through the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry. We have an entrepreneurial spirit and seek to be involved in … Type: | 18 | 3 | 15 | 12 |
 | BrightHeart Advancing prenatal ultrasound screening with AI At BrightHeart, we believe every single fetal ultrasound screening exam should be performed with the highest level of accuracy, so each mother and baby receive the highest possible quality of care. Type: | 2 | 2 | 1 | 12 |
 | Womed This is a women's world Womed is pioneering innovative, safe and effective treatments to free women from challenging uterine pathologies: infertility, uterine bleeding, endometriosis. Type: | 10 | 1 | 1 | 12 |
 | RebrAIn ReBrain standardizes targeting for DBS and brain lesion surgeries in Parkinson and essential tremor diseases RebrAIn offers a precise targeting technology for Deep Brain Stimulation (DBS). This is achieved through an algorithm based on Artificial Intelligence and a collaborative health data registry. With this innovative technology, developed to effectively identify the areas of the brain to be treated, ReBrain simplifies and standardizes DBS by reducing the risks and making it less traumatic, thus allowing more patients worldwide to be treated. Type: | 11 | 7 | 6 | 12 |
 | KREAXI Financing partner for innovative start-ups KREAXI is one of the top French leaders in seed and venture capital, with €150m under management, 550 companies invested since last 30 years (of which 27 went public), 60 active portfolio companies, with a team of 16 persons based in Lyon and Paris. Type: | 37 | 14 | 22 | 13 |
 | PE Cube SaaS for Private Equity with Clarity PE Cube is a SaaS solution for each team member of Private Equity management companies to optimize fund management’s performance while enabling a rich, reliable and transparent communication towards each of its stakeholders. PE Cube is based on 20 years of Private Equity practice and on the key-belief that data is crucial to each level of fund management. This is why PECube is designed to ensure flawless end-to-end processing to express the full potential for monitoring and steering fund management activity. Each general partner member is thus equipped to ensure reliability, security and accessibility … Type: | 40 | 4 | 40 | 13 |
 | Gradient Denervation Technologies Transforming the treatment of pulmonary hypertension A solution for patients suffering from heart failure with pulmonary hypertension. Type: | 1 | 1 | 0 | 13 |
 | VITAL MEAT Sustainable, healthy and delicious cultivated meat 🌎🍴 VITAL MEAT is a cultivated meat start-up based out of Nantes, France 🇫🇷 Our mission is to reduce human impact on the environment by providing HEALTHY, DELICIOUS, ETHICAL and SUSTAINABLE meat to billions of people 🌎 Thanks to our scalable technology and a cost effective process, we are gearing up to commercialize our first chicken product 🐔! Type: | 12 | 4 | 9 | 13 |
 | Bioptimus We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models Type: | 4 | 2 | 3 | 13 |
 | Ulysse Communication [Automatic translation follows] Who better than former journalists to make your voice heard? Ulysse Communication, at the crossroads of press and communication. Specializing in press relations and financial communications, Ulysse Communication was created by former economic and financial journalists who themselves surrounded themselves with former journalists. The agency and the team are strongly marked by this DNA which translates into an intimate knowledge of the media, an ability to develop tailor-made messages and a good understanding of the economic and business world. Press relations, Financial communication, Finance, Listed company, IPO, Financial operations, Public relations, Corporate communication, Asset management, Real estate, … Type: | 41 | 0 | 40 | 14 |
 | Bien Commun Advisory [Automatic translation follows] The conviction that, in the “common good”, the greatest good is first and foremost what is common to us. Bien Commun Advisory is a consulting firm in communications strategy, economic information, public affairs and media relations. Founded by Antoine Boulay in 2019, it now has around fifteen employees and operates for large companies, SMEs, start-ups, federations and players in the associative world. Type: | 34 | 1 | 29 | 14 |
 | Interaction Healthcare [Automatic translation follows] Your strategy deserves the best treatment 100% digital agency specializing in the field of health. Founded in 2008, Interaction Healthcare’s know-how is based on 4 pillars: - digital strategy consulting; - web and social media solutions; - mobile solutions and new interfaces; - digital medical simulation and serious game. Interaction Healthcare designs and develops digital communication and e-training tools for the pharmaceutical industry, university hospitals, simulation centers, learned societies, patient associations, healthcare professionals and the general public. Recognized as an innovative company by the Oséo Excellence 2012 network and partner of INRIa, a digital research laboratory, the … Type: | 41 | 4 | 39 | 15 |
 | Pyrowave Electrifying progress. We are leading the revolution in #sustainable #greenchemistry by offering a modular microwave based technology that can #unzip waste plastics back to their root chemical form. Styrene, Polyolefin wax, Lubricants, Microwave, Plastics, #CircularEconomy, #LowCarbonCement , CleanTechnology, #Nanorecycling, GreenSolutions, and #WasteReduction Type: | 5 | 1 | 4 | 15 |
 | Italian Tech Alliance [Automatic translation follows] Formerly VC Hub Italia, it is the association of Venture Capital, investors in innovation, startups and innovative SMEs Italian Tech Alliance is the reference association for: - venture capital funds; - investors in innovation; - innovative startups and SMEs. The objective of the association is to promote the development of the technology and innovation ecosystem in Italy, working closely with institutions. The contents of the Italian Tech Alliance disseminate news, opportunities and interesting reports for private and public stakeholders who work for the economic and social growth of the country. The following currently sit on the Board … Type: | 7 | 3 | 3 | 15 |
 | Cure51 From Cancer Survivors to new drugs The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer. Type: | 2 | 1 | 0 | 15 |
 | Innogest Capital Investors in companies that make the difference, partner of entrepreneurial visionaries We are investors in companies that make the difference. We trust in great entrepreneurs, we partner with hard-working visionaries. Innogest is a Venture Capital firm focused on seed and early stage ventures, with more than € 200 milion of capital under management. We have over 100 years of cumulative professional experience in the digital and the healthcare fields. Innogest invests in high potential companies through a direct share in their equity and pays special attention to market potential and size. Innogest leverages its extensive network of contacts, working alongside … Tags: H2020 Type: | 4 | 0 | 1 | 16 |
 | May Health We are bringing a modern approach to the treatment of PCOS with our investigational Ovarian Rebalancing Treatment. May Health, formerly AblaCare, is developing a modern approach to PCOS. Type: | 1 | 1 | 1 | 16 |
 | Adjuvant Capital Adjuvant Capital is the leading investment fund focused on public health. Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Type: | 1 | 0 | 1 | 16 |
 | World Bio Markets Driving the commercialisation of the Bioeconomy Join us 26th - 27th June 2024 for the next edition of World Bio Markets. Taking Place at The Hague in the Netherlands, World Bio Markets is the leading international business event connecting over 400 industry leaders with a packed programme of knowledge exchange, 1-2-1 meetings and networking. We bring together the right people, in the right environment in order to accelerate the transition to a fossil-free economy. "I've had two days of back to back meetings to discover companies and technologies that can help us achieve our 2030 sustainability goals. The event has … Type: | 29 | 1 | 27 | 16 |
 | Qorium Real Leather, Reinvented Leather is loved. Leather is luxury. Leather is everywhere. Unfortunately, making leather is also polluting, challenging and controversial. Qorium creates beautiful, premium, and authentic leather without compromise. Cutting-edge science empowers us to dramatically reduce the vast impacts of today’s leather industry without quality reductions. By removing the cow from leather production, Qorium’s material has minimal climate impacts, low water and chemical usage, no land use, and no animal impacts. Simply put, Qorium reinvents leather. Better product. Better planet. Biotechnology, Cell cultured leather, Leather, Cell grown Leather, Sustainable Leather, and Animal free Leather Type: | 1 | 0 | 1 | 16 |
 | Chausson Partners We match smart money with great companies Chausson Finance is a leading fundraising advisory firm, providing deal making and equity story advice, as well as devoted support to inspiring founders. We helped shape +250 deals, and raise $1Bn. Our community of clients include leadership teams funded by Accel, Balderton, Alven and other top venture investors. Fundraising, Corporate Finance, Venture Capital, investment banking, equity rounds, M&A, Series A, Series B, and Equity Financing Type: | 18 | 2 | 16 | 17 |
 | 4BIO Capital London-based venture fund investing in advanced therapies 4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious … Type: | 6 | 2 | 4 | 17 |
 | datacraft [Automatic translation follows] The data scientists club datacraft allows an exchange of best practices between data experts. It is a unique Club model, inspired by companionship, and designed to allow data scientists/data engineers to train among peers and enable companies to accelerate their AI/data projects. Access to the Club is through an annual membership. Type: | 48 | 8 | 35 | 17 |
 | ImmuONE Specialised translational approaches and in vitro testing services ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. … Type: | 4 | 0 | 2 | 17 |
 | SafeHeal Reshaping RecoveryTM Established in 2015 and based in France, SafeHealTM is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented by French surgeon Charam Khosrovani to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device Type: | 2 | 1 | 0 | 18 |
 | Panakes Partners Life Sciences dedicated VC firm Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world, in two funds. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250 million under management. Panakes brings strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our … Type: | 12 | 2 | 7 | 18 |
 | Phacilitate Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences Type: | 4 | 1 | 3 | 18 |
 | Invyo Europe's leading data platform for data-driven investors (Venture Capital / Private Equity / Family Office) Since 2018, INVYO has been the trusted partner for investors in private equity, venture capital and family offices. We are a reference platform in Europe, propelling investors towards a data and tech-driven investment model thanks to AI. Our sector expertise harnesses your data to boost your human and financial performance. - French publisher - More than 50 client funds - 16 data experts - 2 offices: Paris & Madrid - SaaS solutions Our mission : At INVYO, we unleash the potential of investment teams through … Type: | 52 | 4 | 52 | 19 |
 | Founders Future Founded by entrepreneurs for entrepreneurs, we invest financial and human capital in tech and digital startups. Founded by the serial European tech entrepreneur, Marc Ménasé, Founders Future is a venture studio, providing creativity, network, support and productive capital. We've built a investment platform dedicated to entrepreneurs and managed by entrepreneurs, bringing high value and an ambitious mindset. We aim to partner with outstanding personalities, to align stakeholder’s interest and to foster operational partnerships. Our mission is to become a sparring-partner and continuously try to impact the business on the product, go-to-market, business development and talent acquisition. We've hired top-notch operating … Type: | 64 | 26 | 50 | 19 |
 | Kima Ventures We fund ambitious, cohesive teams with stellar learning and execution curves. Investing in 2 to 3 startups per week, all over the world. Type: | 44 | 34 | 1 | 19 |
 | Thuja Capital Healthcare Investors Thuja Capital is an early-stage venture capital firm located in Utrecht, The Netherlands. We invest in product focused companies that aim to have true impact for patients and doctors alike, as demonstrated in clinical studies to enable a health claim. Hence most of our ventures are active in the field of therapeutics, medical devices and digital health. Not only do we invest, we also take an active role in helping the company to become successful, by leveraging our extensive network and by bringing our own experience to the table. red biotechnology, life sciences, medical technology, diagnostics, medical devices, … Type: | 6 | 2 | 5 | 19 |
 | Longwood Fund Longwood creates and invests in science-based companies that develop novel solutions for important medical problems Longwood creates and invests in science-based companies that develop novel solutions for important medical problems. Healthcare and Biotech and entrepreneurialism Type: | 4 | 1 | 0 | 19 |
 | Crédit Mutuel Innovation [Automatic translation follows] Our relationships bring value Crédit Mutuel Innovation is the subsidiary specializing in venture capital investments of Crédit Mutuel Equity (€4 billion in capital managed). It invests in equity tickets of between €1 and €20 million in innovative deeptech, digital and life sciences companies. Crédit Mutuel Innovation allows entrepreneurs to develop their growth potential by connecting them to companies in its ecosystems. Because it takes more than 5 years to create a world leader, Crédit Mutuel Innovation invests its own capital sustainably and builds long-term relationships with the entrepreneurs it supports. Type: | 44 | 22 | 31 | 19 |
 | Cellomatics Biosciences Ltd Our expertise, Your discovery Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies. Multiplex Immunoassay, Target and biomarker validation, In vitro functional assays, Molecular Biology, Receptor binding, Toxicity testing, Immuno-Oncology, Oncology, Immunology, Inflammation, and Respiratory Type: | 1 | 0 | 0 | 20 |
 | Cyber Valley Europe’s largest AI research consortium Cyber Valley is Europe’s largest and leading research consortium in the field of artificial intelligence (AI) and modern robotics. Cyber Valley has a mission and a public mandate to advocate for entrepreneurship, research, development, application, and acceptance of technologies and methods in the field of intelligent systems. The company envisions a future where the full potential of intelligent systems is leveraged for the greater good of the world. The Cyber Valley Community connects partners from science, industry, and society, along with AI researchers and entrepreneurs. The Cyber Valley GmbH is funded by the state of … Type: | 9 | 1 | 6 | 20 |
 | PariSanté Campus [Automatic translation follows] ParisSanté Campus, here grows digital health! PariSanté Campus aims to create a coherent and synergistic set of public and private operators, with the ambition of structuring a digital health research and innovation sector with global reach. This group will aim to be established on the site of the former Val-de-Grâce army training hospital, and to create a network of Ile-de-France, national and international partnerships. The whole will be financed by unprecedented investments from the recovery plan, and will be intended to be a major vector for creating medical-scientific, but also economic, value. Based on a complete chain … Type: | 77 | 24 | 47 | 20 |
 | BIOWEG Revolutionizing the Future of Bio-ingredients BIOWEG, founded in 2019 in Germany, is a purpose-driven organization powered by conscious ChemDesign. We match Bio-innovation to business problems. We explore and combine biotechnology, material science, and molecular simulation learning to create advanced sustainable bio-based high-performance ingredients. Our ingredients are 100% animal free, globally scalable, and sustainably produced without harsh chemicals. We work with results-oriented, forward-thinking companies, and consumer brands with global scale in the cosmetics, personal care, nutraceuticals, agricultural coatings, and food/beverage sectors who desire highly differentiated and sustainable science-based ingredient technologies. Material Science, Fermentation , Green Chemistry, Alternative Ingredients, Biobased Materials, Biodegradabe, … Type: | 22 | 3 | 2 | 20 |
 | Osage University Partners (OUP) Venture capital for university innovation. All sectors, all stages, all in. Osage University Partners (OUP) is a venture capital fund that invests exclusively in startups that are commercializing university research. OUP firmly believes that universities provide an unparalleled innovation engine and we have partnered with over 100 of the most entrepreneurial universities and research centers to invest in their startups. Profits are shared with affiliated institutions to further promote the university entrepreneurial ecosystem. Physical Sciences, Life Science, entrepreneurship, University Innovation, VC, Venture Capital, investing, startups, university startup, technology transfer, biotech, and science Type: | 5 | 1 | 4 | 20 |
 | ISALT [Automatic translation follows] Financing the new French industry and meeting the challenge of transitions “Our objective is to help French companies grow through long-term investment” ISALT is a portfolio management company whose mission is to invest long-term in the capital of listed or unlisted French companies. Since its creation in 2020, ISALT has set itself the ambition of developing a long-term investment platform with the aim of providing stable and constructive capital to French companies operating in key sectors for our economy. As such, it implements an investment strategy which consists of taking significant, long-term stakes in the capital of … Type: | 7 | 5 | 2 | 20 |
 | Regeneration.VC Supercharging Consumer-Powered Climate Innovation Regeneration.VC is an early-stage venture fund Supercharging Consumer-Powered Climate Innovation driven by circular and regenerative principles. We invest in Consumer ClimateTech companies that generate outsized economic and environmental outcomes across three strategies: Design (AgTech & Aquaculture and Next-Gen Materials), Use (Apparel & Lifestyle and Food & Beverage brands), and Reuse (ReCommerce and Reverse Logistics system technologies). Have an innovation ready to supercharge? Submit here: https://form.fillout.com/t/dDYPidgNx4us Circular Economy, Sustainable Investing, Venture Capital, Consumer, Climate Tech, Regeneration, and Consumer ClimateTech Type: | 38 | 0 | 38 | 21 |
 | Nuage Therapeutics We develop new selective and potent drugs for intrinsically disordered targets. Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs. Type: | 4 | 1 | 2 | 21 |
 | GTM Forum Navigate the Go to market landscape GTM Forum is your premier analyst partner in go-to-market strategies, serving leading B2B companies worldwide. Our expertise across multiple sectors uniquely positions us to address your complex challenges effectively. With our broad knowledge base and global reach, we are dedicated to making a significant impact on both our clients and the community. We create a collaborative environment that boosts your team's capabilities and leadership, providing tailored support to tackle fundamental issues and offer practical solutions. Our mission is to empower your organization to drive and maintain progress in your strategic endeavors. Specializing in mid-market … Type: | 33 | 0 | 33 | 23 |
 | BIOTECanada Solving for today. Building for tomorrow. BIOTECanada serves as the national voice for Canada’s biotechnology sector. BIOTECanada is the national industry-funded association with over 250 member companies representing the broad spectrum of biotech constituents including emerging and established firms in the health, industrial, and agricultural sectors, as well as academic and research institutions and other related organizations. Through our national network of partner organisations, we inspire our domestic and international community to recognize the value of biotechnology and to provide solutions to the challenges faced by biotech firms today. Visit us at www.biotech.ca, and discover Canada's Biotechnology and Lifesciences Community … | 6 | 1 | 5 | 25 |
 | Science Entrepreneur Club Building communities. Enabling innovation. Connecting the life science ecosystem. We’re a non-profit on a mission to build meaningful communities to enable innovation and connect the life science ecosystem. We're building communities for entrepreneurs building in bio, investors actively backing life science companies and academics looking to break into industry. The SEC is the home of the BioFounder Club, BioCapital Network and BioAcademic Hub. entrepreneurship, innovation, science, engineering, life science, biotech, startup, networking, technology, and health Type: | 10 | 0 | 11 | 25 |
 | Virtonomy.io Accelerate and de-risk medical device development with digital patient twins and simulation Virtonomy introduces v-Patients, enabling medical device developers to perform development and testing in a virtual environment, thereby accelerating development, reducing risks, expenses, and regulatory burden. Our end-to-end digital twin and simulation solution is based on an ever-expanding database of real clinical data to reflect anatomical variability, demographic diversity and pathological conditions. digital health, virtual patients, digital twins, clinical trials, simulation, machine learning, AI, SaaS, simulated trials, cardiac database, and medtech Type: | 4 | 0 | 4 | 26 |
 | AlbionVC Backing visionary founders with long-term capital & scale-up expertise. Partners to B2B software & healthcare companies. AlbionVC supports visionary founders with long-term capital and scale-up expertise. Founded in 1996, today we are partners to UK early-stage B2B software and healthcare companies. AlbionVC manages c. $1 billion of venture funds, currently invested in over 50 companies. AlbionVC is the technology investment arm of Albion Capital Group LLP, which is authorised and regulated by the Financial Conduct Authority. Type: | 23 | 5 | 21 | 27 |
 | International Union of Crystallography Advancing crystallography and structural science through primary research publication and extensive outreach activities The IUCr is an International Scientific Union. Its objectives are to promote international cooperation in crystallography and to contribute to all aspects of crystallography, to promote international publication of crystallographic research, to facilitate standardization of methods, units, nomenclatures and symbols, and to form a focus for the relations of crystallography to other sciences. Publishing, Crystallography, Open Access, Science, journals, online communities, and databases Type: | 12 | 0 | 11 | 27 |
 | Phytolon Natural Food Colors Phytolon offers natural food colors, uniquely positioned to comply with the consumers needs for healthy food, and with the industry requirements for cost-efficiency and high quality. Phytolon leverages a novel and sustainable fermentation-based technology by which betalain natural colors are produced in baker's yeast. food colors, natural ingredients, yeast, fermentation, sustainability, biotechnology, and foodtech Type: | 2 | 0 | 2 | 27 |
 | Tenpoint Therapeutics Ltd Vision-restoring engineered cell-based therapeutics & in vivo reprogramming. Tenpoint Therapeutics is a vision-restoring engineered cell-based therapeutics company. We are embracing a new opportunity to fundamentally reshape the future for people with ocular diseases. We have an ambitious goal with global impact. Type: | 2 | 2 | 0 | 27 |
 | Predict4Health AI-powered Precision Medicine for Organ Failure Our mission is to improve patients’ live and healthcare systems by postponing organ failure with the power of AI. 💪 Our products : 📊 A Decision making tool based on iBox : Predigraft helps physicians monitor transplanted patients by providing allograft survival prognosis. 📱 A Smart telemonitoring of chronic patients : Apilife is a fully connected platform acting as a medical hub for patients and their medical teams. 🧬 A Digital Biomarker for clinical trials : Our technology can be used to design clinical trials and to assess kidney allograft survival. Medicine, Machine Learning, … Type: | 39 | 5 | 30 | 28 |
 | EuropaBio - the European Association for Bioindustries Innovative biotechnology, benefiting people and planet. EuropaBio, the European Association for Bioindustries, promotes an innovative and dynamic European biotechnology industry. EuropaBio and its members are committed to the socially responsible use of biotechnology to improve quality of life, to prevent, diagnose, treat and cure diseases, to improve the quality and quantity of food and feedstuffs and to move towards a biobased and zero-waste economy. Type: | 21 | 6 | 18 | 29 |
 | Supernova Invest European deeptech VC, focused on high-growing start-ups and cutting-edge technologies Supernova Invest is a European multi-stage VC firm with currently €800m AUM. Our team provides unparalleled expertise and smart capital in the fields of Healthcare, Energy & Environment, Industry 4.0, and Digital technologies to support high-growth, deeptech start-ups and scale them globally. We support disruptive tech companies such as Soitec, Ynsect, Alice & Bob, Gleamer, Aledia, Crowdsec, UnitySC and Robocath. The Supernova team exited +25 companies through top IPO and M&A deals. The team is composed of 25+ experienced investors with a unique ability to understand both the underlying technologies … Type: | 54 | 18 | 38 | 29 |
 | OBN (UK) Ltd The membership organisation supporting & bringing together UK’s life sciences companies, corporate partners & investors OBN is the membership organisation supporting and bringing together the UK's emerging life science companies, corporate partners and investors. Our 450+ member companies are located across the Golden Triangle and beyond, and benefit from our networking, partnering, purchasing, advising, and advocacy activities. OBN organises BioTrinity - Europe's Leading Investment and Biopartnering Conference, find out more at www.biotrinity.com. Networking Events, Partnering (BioTrinity), Advising: Cluster Analysis and Business Development, Group Purchasing Consortium, Advocacy, Conferences, BioTech, and Life Sciences Type: | 8 | 4 | 4 | 29 |
 | ENYO Pharma Developing therapeutics for diseases with impaired kidney function ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor. Type: | 8 | 3 | 5 | 31 |
 | Mosaic TX An oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients. ABOUT US Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety … Type: | 2 | 1 | 1 | 31 |
 | Cambridge Innovation Capital A leading venture investor in Cambridge backing and building category-leading deep tech and life sciences companies. Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. CIC currently manages over £500 million and has invested in 30+ companies. We invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics. IP Commercialisation, Venture Capital, healthcare, … Type: | 13 | 4 | 5 | 32 |
Media